Clinical trial
Stereotactic Accelerated Radiotherapy in GlioblastomA (SAGA)
NCT05781321 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stereotactic Accelerated Radiotherapy in GlioblastomA (SAGA)
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- March 23, 2023
- Completion date
- November 30, 2028
- Enrollment
- 170 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.